Ovarian Cancer

Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.

Overview

Feature Articles

Latest Ovarian Cancer News and Research

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

Study shows how XRCC1 gene untangles proteins that trigger cancerous tumors

Study shows how XRCC1 gene untangles proteins that trigger cancerous tumors

Odor-based test could serve as a non-invasive approach to screen for harder-to-detect cancers

Odor-based test could serve as a non-invasive approach to screen for harder-to-detect cancers

New biomarker could be used to determine resistance of ovarian cancer to platinum chemotherapy

New biomarker could be used to determine resistance of ovarian cancer to platinum chemotherapy

Postmenopausal women who underwent bilateral oophorectomy have increased risk of carpal tunnel syndrome

Postmenopausal women who underwent bilateral oophorectomy have increased risk of carpal tunnel syndrome

Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individuals

Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individuals

Early detection of ovarian cancer does not translate into saving lives

Early detection of ovarian cancer does not translate into saving lives

Risk prediction model does not accurately identify lung cancer risks in diverse population

Risk prediction model does not accurately identify lung cancer risks in diverse population

New drug class effective in treating certain types of ovarian cancers

New drug class effective in treating certain types of ovarian cancers

Rucaparib drug  is effective in treating certain types of ovarian cancers, shows study

Rucaparib drug is effective in treating certain types of ovarian cancers, shows study

Drug synthesized from Kentucky-grown plant shows promise in treating ovarian cancer

Drug synthesized from Kentucky-grown plant shows promise in treating ovarian cancer

1 in 6 patients with colorectal cancer found to have inherited genetic mutations

1 in 6 patients with colorectal cancer found to have inherited genetic mutations

Modified immune cells may prove a game-changer for patients with late-stage cancers

Modified immune cells may prove a game-changer for patients with late-stage cancers

Study reveals new insights into the effects of chemotherapy on tumor microenvironment

Study reveals new insights into the effects of chemotherapy on tumor microenvironment

Stress incontinence surgery does not increased risk of pelvic cancers

Stress incontinence surgery does not increased risk of pelvic cancers

Advancing the Diagnosis and Treatment of Ovarian Cancer

Advancing the Diagnosis and Treatment of Ovarian Cancer

New research could rescue failed immunotherapies for treating solid tumors

New research could rescue failed immunotherapies for treating solid tumors

Researchers define genetic landscape of uterine leiomyosarcomas

Researchers define genetic landscape of uterine leiomyosarcomas

Despite guidelines, end-of-life care remains aggressive for ovarian cancer patients

Despite guidelines, end-of-life care remains aggressive for ovarian cancer patients